...
机译:IAPS的拮抗作用增强了汽车T细胞效力
Peter MacCallum Canc Ctr Canc Immunol Program Melbourne Vic Australia;
Peter MacCallum Canc Ctr Canc Immunol Program Melbourne Vic Australia;
Peter MacCallum Canc Ctr Canc Immunol Program Melbourne Vic Australia;
Peter MacCallum Canc Ctr Translat Haematol Program Melbourne Vic Australia;
Peter MacCallum Canc Ctr Canc Immunol Program Melbourne Vic Australia;
Univ Melbourne Sir Peter MacCallum Dept Oncol Parkville Vic Australia;
Univ Melbourne Sir Peter MacCallum Dept Oncol Parkville Vic Australia;
Walter &
Eliza Hall Inst Med Res Cell Signalling &
Cell Death Div Parkville Vic Australia;
Univ Melbourne Sir Peter MacCallum Dept Oncol Parkville Vic Australia;
Univ Melbourne Sir Peter MacCallum Dept Oncol Parkville Vic Australia;
Walter &
Eliza Hall Inst Med Res Cell Signalling &
Cell Death Div Parkville Vic Australia;
Peter MacCallum Canc Ctr Canc Immunol Program Melbourne Vic Australia;
Peter MacCallum Canc Ctr Canc Immunol Program Melbourne Vic Australia;
Peter MacCallum Canc Ctr Canc Immunol Program Melbourne Vic Australia;
Peter MacCallum Canc Ctr Canc Immunol Program Melbourne Vic Australia;
机译:IAPS的拮抗作用增强了汽车T细胞效力
机译:TET2破坏增强了CD19汽车T细胞疗法的疗效
机译:递增的呈现一种剂量的5-AZA-2'-丁氧基胞苷通过改善T细胞持久性提高了小鼠模型中的Cart-Cell治疗治疗效果
机译:提高嵌合抗原受体T细胞治疗肿瘤治疗疗效的主要问题及目前策略
机译:在易患共病抑郁和心血管疾病的啮齿动物模型中,血管紧张素受体拮抗作用的疗效的临床前证据。
机译:铠装CAR T细胞:利用细胞因子和促炎配体增强CAR T细胞的抗肿瘤功效
机译:IAPS的拮抗作用增强了汽车T细胞效力